Drug Shortage Report for SANDOZ DOCUSATE SODIUM
Report ID | 219987 |
Drug Identification Number | 02247385 |
Brand name | SANDOZ DOCUSATE SODIUM |
Common or Proper name | DOCUSATE SODIUM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DOCUSATE SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 1000SGC |
ATC code | A06AA |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-20 |
Estimated end date | |
Actual end date | 2024-05-01 |
Shortage status | Resolved |
Updated date | 2024-05-02 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-05-02 | English | Compare |
v6 | 2024-05-01 | French | Compare |
v5 | 2024-05-01 | English | Compare |
v4 | 2024-02-21 | English | Compare |
v3 | 2024-02-20 | French | Compare |
v2 | 2024-02-20 | English | Compare |
v1 | 2024-02-20 | English | Compare |
Showing 1 to 7 of 7